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Fig. 1. An overview of cytoplasmic poly(A)+ mRNA decay pathways. A – degradation mechanisms initiated by disruption             
of the closed circle mRNA structure and deprotection of mRNA termini. The roles of deadenylation, 3'-terminal uridylation, Ski 
complex/Ski7 protein and decapping in the stimulation of 3'-5' exonucleases (Dis3/Dis3l associated with the exosome core             
or Dis3l2) and 5'-3' exonuclease (Xrn1) are described in sections 1.1-1.6. B – mRNA degradation in specialized and quality control 
pathways can be also initiated by endonucleolytic cleavage within the transcript body. This leads to the exposure of unprotected      





































































Fig. 2. Schematic presentation of poly(A)- histone-coding mRNA decay pathway in mammalian cells. See section 1.7 for details    
on ERI1 3'-5' exonuclease action and the role of repetitive uridylation in the removal of stem-loop (SL) structure, recruitment          of 
decapping factors mediated by LSM1-7 complex and the involvement of exosome, DIS3L2 and HBS1/PELOTA heterodimer in the 
degradation process. 












































































Fig. 3. Cytoplasmic pathways of tRNA (A), rRNA (B), vault RNA and Y RNA (C) degradation. See sections 2.1, 2.2, and 2.3 for 
details, respectively. A – aberrant yeast tRNAs can undergo RTD (rapid tRNA decay), or be removed followed addition of CCACCA 
sequence by tRNA terminal nucleotidyltransferase. B – defective rRNAs (18S and 25S) are degraded in yeast via respective, distinct, 
NRD (non-functional rRNA decay) mechanisms; in addition, stress-induced endonucleolysis can also initiate rRNA decay. C – vault 
and Y RNAs are short, structured, human transcripts, degraded most likely by uridylation-stimulated DIS3L2 exonucleolytic 






































Fig. 4. Quality control of human snRNA biogenesis. See section 2.4 for a more detailed description. snRNA read-through transcripts 
can be degraded by the exosome/DIS3 already in the nucleus. snRNAs defective in snRNP formation are degraded in the cytoplasm 
by decapping/XRN1 5'-3' pathway. 3'-extended snRNA precursors may escape from the nucleus to the cytoplasm, where they are 






















































































Fig. 5. Decay pathways for pre-miRNAs and miRNAs (A), piRNAs (B) and endo-siRNAs (C). See sections 2.5, 2.6, and 2.7 for 
details, respectively. A – miRNA biogenesis is a multi-step pathway, beginning with the synthesis of pri-miRNAs, which are 
processed to pre-miRNAs in the nucleus. Pre-miRNAs are then exported to the cytoplasm and further processed to miRNA duplexes. 
Each of the miRNA biogenesis intermediates can undergo degradation in the cytoplasm, since pri-miRNAs are known to escape to 
the latter compartment. Such pri-miRNAs can be degraded by Tudor-SN, following modiﬁcation by ADAR. In turn, pre-miRNAs 
are known to be degraded by exosome/DIS3/RRP6 in conjunction with uridylation, or undergo MCPIP endonucleolytic cleavage. 
Pre-miRNAs from let-7 family are oligouridylated by TUTases with the help of LIN28, and subsequently degraded by DIS3L2. 
Mature miRNAs can be degraded from both 5'-end (by enzymes from XRN family) and 3'-end (by various exonucleolytic activities, 
including exosome, RRP6, PARN, ERI1, PNPase, SDN), depending on the organism and miRNA species. In human cells, target-
mediated miRNA degradation (TDMD) path, dependent on uridylation and DIS3L2 activity, was discovered. B – piRNAs are 
protected from degradation through association with Piwi proteins, as well as owing to Hen1-mediated 2'-O-methylation of the 3'-
terminus; piRNAs lacking this modiﬁcation undergo uridylation and degradation by an unknown exonuclease. C – endo-siRNAs 
degradation is controlled similarly to piRNAs; in addition, dsRNA being the source of endo-siRNAs can be modiﬁed by ADAR and 





















































Fig. 6. Degradation of pervasive transcription products in eukaryotic cells. See section 2.8 for details. A large fraction of eukaryotic 
genomes is transcribed, giving rise to a variety of unstable ncRNA species, which are degraded by different mechanisms. While 
many of them undergo exosome- and/or Xrn2-mediated degradation already in the nucleus, some of them escape to the cytoplasm, 
where their decay takes place. For instance, degradation of XUTs and CUTs in yeast is dependent on Xrn1p, and decay of the latter 
may require also decapping enzyme and some NMD factors. CircRNAs (circular RNAs) in human cells do not have free ends, so 
their degradation is initiated by endonucleolytic cleavage, possibly assisted by miRNA. ncRNAs originating from repetitive DNA 
elements, such as LINEs or SINEs are degraded by distinct, not yet fully explored mechanisms, involving the action of RNase L, 
MOV10 helicase and ZAP protein (LINEs) or DICER1 (Alu family of SINEs). BC200 Alu-related element is in turn degraded with 
the help of DIS3L2.
